Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Reform Obstruction By Republicans May Backfire, Pollsters Suggest

This article was originally published in The Pink Sheet Daily

Executive Summary

Republican efforts to hamper implementation of the health reform law following the Nov. 2 elections may not help the party's prospects in the 2012 presidential election, Democratic pollsters suggested during an Oct. 27 discussion sponsored by Health Affairs.

You may also be interested in...



PhRMA Donations To Political Campaigns Reflect Makeup Of Congress, Group Says

The skewing of the Pharmaceutical Research and Manufacturers of America’s PAC political campaign donations in favor of Democrats reflects the current makeup of Congress rather than an attempt to influence the outcome of the 2010 midterm elections, the organization maintains.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says

Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS071377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel